Valeant swings to profit on tax gain, raises forecast
(Reuters) – Canada’s Valeant Pharmaceuticals International Inc reported its first profit in six quarters, helped by a one-time tax gain, and raised its full-year earnings forecast, sending its U.S. shares up 13...
Read More